Anti‐angiogenic therapy for lung cancer
References
Additional references
Non‐small Cell Lung Cancer Collaborative Group. Chemotherapy in non‐small cell lung cancer: A meta‐analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal 1995;311:899‐909.
Bonfill X, Serra C, Sacristan M, Nogue M, Losa F, Montesinos J. Second‐line chemotherapy for non‐small cell lung cancer. Cochrane Database of Systematic Reviews 2002, Issue 2.
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407(6801):249‐57.
Coussens LM, Fingleton B, Matrisian LM. Matrix Metalloproteinase Inhibitors and Cancer‐Trials and Tribulations. Science 2002;295 (5564):238792.
Dvorak HF. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumour Angiogenesis and a Potential Target for Diagnosis and Therapy. Journal of Clinical Oncology 2002;20(21):4368‐80.
Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney International 1999;56 (3):794‐814.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Medicine 2003;9 (6):669‐76.
Folkman J. Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 1971;285(21):1182‐6.
Gasparini G, Longo R, Fanelli M, Teicher BA. Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions. Journal of Clinical Oncology 2005;23(6):1295‐311.
Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, et al. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non Small‐Cell Lung Cancer Previously Treated With Chemotherapy. Journal of Clinical Oncology 2004;22(9):1589‐97.
Herbst RS, Onn A, Sandler A. Angiogenesis and Lung Cancer: Prognostic and Therapeutic Implications. Journal of Clinical Oncology 2005;23 (14):3243‐56.
Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8.5 The Cochrane Collaboration's tool for assessing risk of bias. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nature Reviews. Cancer 2002;2(10):727‐39.
Kerbel RS. Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer. Science 2006;312 (5777):1171‐5.
Kumar S, Witzig TE, Rajkumar SV. Thalidomide: Current Role in the Treatment of Non‐Plasma Cell Malignancies. Journal of Clinical Oncology 2004;22(12):2477‐88.
Parmar MK, Torri V, Stewart L. Extracting summary statistics toperform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
Peterson P, Park K, et al. Is pemetrexed more effective in patients with non‐squamous histology. A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non small cell lung cancer (NSCLC). European Journal of Cancer 2007;5 (S363):6521.
Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S, et al. American Society of Clinical Oncology Treatment of Unresectable Non‐Small Cell Lung Cancer Guideline: Update 2003. Journal of Clinical Oncology 2004;22 (2):330‐53.
Rami‐Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Annals of Thoracic and Cardiovascular Surgery 2009;15(1):4‐9.
Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using Pubmed. International Journal of Epidemiology 2002;31(1):150‐3.
Scagliotti G, Purvish P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non‐small cell lung cancer (NSCLC). Journal of Thoracic Oncology 2007;2 (8 Supp 4):S306 (PRS‐03).
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non‐small cell lung cancer. New England Journal of Medicine 2002;346(2):92‐8.
Simon GR, Wagner H. Small Cell Lung Cancer. Chest 2003;123(90010):259S‐271.
